Infection Control Today Magazine

Herpes

Kaiser Permanente Study Finds No Serious Reactions to Shingles Vaccine

The herpes zoster vaccine, also known as the shingles vaccine, is generally safe and well tolerated according to a Vaccine Safety Datalink study of 193,083 adults published online in the Journal of Internal Medicine. More than 1 million people develop shingles every year in ...More
April 23, 2012
Posted in News
New Indicator Diseases Reveal Hidden HIV

Today, heterosexuals in Europe are at particular risk of carrying HIV for so long that they remain undiagnosed until their immune system starts to fail and they become ill. An international study under the leadership of the HIV in Europe initiative has now revealed that a ...More
March 1, 2012
Posted in News
Research Shows Progress Toward a Genital Herpes Vaccine

Robert Belshe, MD, led national research on an investigational genital herpes vaccine, which was reported in the New England Journal of Medicine. An investigational vaccine protected some women against infection from one of the two types of herpes simplex viruses that cause ...More
January 5, 2012
Posted in News
The Private Nuclear Rooms of Herpesviruses

Researchers from Princeton University have discovered why, despite being bombarded by many different herpesviruses, infected cells produce only a limited number of those viruses. They report their findings in the current issue of the online journal mBio. Herpes viruses are ...More
January 4, 2012
Posted in News
Gene is the First to be Linked to Herpes-Related Cold Sores

A team of researchers from the University of Utah and the University of Massachusetts has identified the first gene associated with frequent herpes-related cold sores. The findings were published in the Dec. 1, 2011 issue of the Journal of Infectious Diseases. Herpes ...More
November 30, 2011
Posted in News, Infections & Pathogens
Say Goodbye to Cold Sores?

Herpes infections on the lips, in the eyes or on the nose are painful, long-lasting and unpleasant. A new 3D herpes infection model brings hope: active ingredients and new treatments can be reliably tested with this model. Animal tests could soon be a thing of the past. ...More
June 28, 2011
Posted in News
Shingles May be Related to Elevated Risk of Multiple Sclerosis

Taiwanese investigators have found that there can be a significantly higher risk of multiple sclerosis (MS) occurring in the year following a shingles, or herpes zoster, attack. The findings, which support a long-held view on how MS may develop, are published in the Journal ...More
June 8, 2011
Posted in News
Persons With Herpes Simplex Virus Type 2, but Without Symptoms, Still Shed Virus

Persons who have tested positive for herpes simplex virus type 2 (HSV-2) but do not have symptoms or genital lesions still experience virus shedding during subclinical (without clinical manifestations) episodes, suggesting a high risk of transmission from persons with ...More
April 12, 2011
Posted in News
Researchers Link Herpes to Alzheimer's Disease

Laboratories at the University of New Mexico (UNM), Brown University, and House Ear Institute (HEI) have developed a new technique to observe herpes simplex virus type 1 (HSV1) infections growing inside cells. HSV1, the cause of the common cold sore, persists in a latent ...More
April 4, 2011
Posted in News
FDA Approves Zostavax Vaccine to Prevent Shingles in Individuals Age 50-59

The Food and Drug Administration (FDA) today approved the use of Zostavax, a live attenuated virus vaccine, for the prevention of shingles in individuals 50 to 59 years of age. Zostavax is already approved for use in individuals 60 years of age and older. In the United ...More
March 25, 2011
Posted in News